Back to search
FDAFDA · Food and drugs·Recall number D-0245-2019

Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00

Published November 21, 2018 · Recall initiated: October 26, 2018

Summary

FDA records drug Class III recall D-0245-2019, published November 21, 2018 and initiated October 26, 2018. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 1 vial; Lot: Lot #: A0A0253, Exp. 02/2019; Lot #: B0369427-112717, Exp. 08/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
1 vial was distributed to a medical facility in Mayville, NY.
Lot
Lot #: A0A0253, Exp. 02/2019; Lot #: B0369427-112717, Exp. 08/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00 recalled?

Yes. FDA published recall D-0245-2019 on November 21, 2018. Reported hazard: Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter